| Financial Year |
March 31 2023 |
| Monetary Funds |
13,967,520,036.00 |
| Held-for-trading Financial Assets |
32,883,691.62 |
| Notes Receivable |
75,290,696.15 |
| Accounts Receivable |
9,220,722,038.32 |
| Advances to Suppliers |
99,686,534.44 |
| Other Receivables |
61,476,374.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
17,550,576,649.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,596,092,314.54 |
| Total Current Assets |
42,899,057,610.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
366,933,484.49 |
| Investment Properties |
88,302,021.69 |
| Fixed Assetes |
1,185,494,889.70 |
| Under-construction Projects |
843,903,055.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
364,842,842.44 |
| R&D expenses |
-- |
| Goodwill |
643,015.39 |
| Long-Term Deferred and Prepaid Expenses |
91,293,881.00 |
| Deferred Income Tax Assets |
400,512,426.75 |
| Other Non-Current Assets |
41,816,702.25 |
| Sub-Total of Non-Current Assets |
3,438,307,122.94 |
| Total Assets |
46,337,364,733.85 |
| Short-Term Loans |
3,291,815,509.52 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,089,832,542.91 |
| Accounts Payable |
9,526,585,062.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
622,642,045.02 |
| Taxes Payable |
236,672,241.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
193,208,070.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
197,867,736.08 |
| Other Current Liabilities |
2,390,124,828.86 |
| Sub-Total of Current Liabilities |
18,796,856,268.77 |
| Long-term Loans |
9,267,845,639.37 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
735,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
298,940,407.79 |
| Deferred Income Tax Liabilities |
15,952,493.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,749,487,125.11 |
| Total Liabilities |
28,546,343,393.88 |
| Paid-In Capital(Or Share Stock) |
1,463,709,516.00 |
| Capital Surplus |
6,703,974,553.12 |
| Surplus Reserve |
732,093,402.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,499,066,117.93 |
| Minority Stockholder's Interest |
338,174,959.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,452,846,380.78 |
| Owner's Equity（Stockholder's Equity） |
17,791,021,339.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
46,337,364,733.85 |
